Incyte Forecast, price target & analysts
Incyte Target price 2025 - Analyst rating & recommendation
Incyte Classifications & Recommendation:
Incyte Price Target
| Target Price | $74.46 |
| Price | $68.37 |
| Potential |
8.91%
register free of charge
|
| Number of Estimates | 24 |
|
24 Analysts have issued a price target Incyte 2026 .
The average Incyte target price is $74.46.
This is
8.91%
register free of charge
$112.35
64.33%
register free of charge
$52.52
23.18%
register free of charge
|
|
| A rating was issued by 33 analysts: 16 Analysts recommend Incyte to buy, 16 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Incyte stock has an average upside potential 2026 of
8.91%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.24 | 4.81 |
| 14.76% | 13.48% | |
| EBITDA Margin | 3.19% | 31.69% |
| 82.52% | 893.82% | |
| Net Margin | 0.77% | 23.82% |
| 95.24% | 2,997.05% |
28 Analysts have issued a sales forecast Incyte 2025 . The average Incyte sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Incyte EBITDA forecast 2025. The average Incyte EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
29 Incyte Analysts have issued a net profit forecast 2025. The average Incyte net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.15 | 5.92 |
| 94.34% | 3,846.67% | |
| P/E | 11.56 | |
| EV/Sales | 2.26 |
29 Analysts have issued a Incyte forecast for earnings per share. The average Incyte EPS is
This results in the following potential growth metrics and future valuations:
Current Incyte Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stifel |
Locked
➜
Locked
|
Locked | Jun 16 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Jun 03 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | May 27 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Stifel:
Locked
➜
Locked
|
Jun 16 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Jun 03 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 27 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Apr 21 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 24 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
